Sign in

CIK 0001384101 · Large accelerated filer

VERACYTE, INC.

Sign in to watch
Ticker
VCYT
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
205455398
Phone
(650) 243-6300
Business address
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
Former names
CALDEROME INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$2,858,989
in 9 filings, $2.9M under 10b5-1 plans

Net −$2,858,989. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-03-02 Stapley Marc Chief Executive Officer Shares withheld for taxes −19,455 $36.01 $701K 403,077
2026-02-26 Leite John Chief Commercial Officer-CLIA Grant or award +47,149 129,262
2026-02-26 Leite John Chief Commercial Officer-CLIA Shares withheld for taxes −8,905 $38.75 $345K 120,357
2026-02-26 McGuire Annie SVP, General Counsel Grant or award +50,999 119,133
2026-02-26 McGuire Annie SVP, General Counsel Shares withheld for taxes −10,867 $38.75 $421K 108,266
2026-02-26 Chambers Rebecca Chief Financial Officer Grant or award +59,324 168,820
2026-02-26 Chambers Rebecca Chief Financial Officer Shares withheld for taxes −12,049 $38.75 $467K 156,771
2026-02-26 Febbo Phillip G. Chief Scientific & Med Officer Grant or award +71,806 161,292
2026-02-26 Febbo Phillip G. Chief Scientific & Med Officer Shares withheld for taxes −24,486 $38.75 $949K 136,806
2026-02-26 Stapley Marc Chief Executive Officer Grant or award +139,074 458,373
2026-02-26 Stapley Marc Chief Executive Officer Shares withheld for taxes −35,841 $38.75 $1.4M 422,532
2025-12-16 McGuire Annie SVP, General Counsel Sale 10b5-1 −10,639 $43.13 $459K 67,860
2025-12-16 McGuire Annie SVP, General Counsel Sale 10b5-1 −100 $43.68 $4K 67,760
2025-12-05 EASTHAM KARIN Director Option exercise 10b5-1 +10,000 $7.94 $79K 23,554
2025-12-05 EASTHAM KARIN Director Option exercise 10b5-1 +10,000 $7.60 $76K 33,554
2025-12-05 EASTHAM KARIN Director Sale 10b5-1 −6,392 $44.52 $285K 27,162
2025-12-05 EASTHAM KARIN Director Sale 10b5-1 −12,808 $45.84 $587K 14,354
2025-12-05 EASTHAM KARIN Director Sale 10b5-1 −800 $46.59 $37K 13,554
2025-12-05 EASTHAM KARIN Director Option exercise · Stock Option (right to buy) 10b5-1 −10,000 0
2025-12-05 EASTHAM KARIN Director Option exercise · Stock Option (right to buy) 10b5-1 −10,000 0

Page 5 of 9 · 168 trades